masoprocol has been researched along with Carcinoma, Small Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bunjobpon, W; Fessler, S; Freer, IK; Glaser, M; Liu, T; McDonald, RW; Pardo, OE; Robins, DJ; Seckl, MJ | 1 |
Avis, IM; Boyle, T; Jett, M; MartÃnez, A; Moody, T; Mulshine, JL; Treston, AM; Vos, MD | 1 |
2 other study(ies) available for masoprocol and Carcinoma, Small Cell
Article | Year |
---|---|
Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Humans; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Lung Neoplasms; Masoprocol; Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Base Sequence; Carcinoma, Small Cell; Carrier Proteins; Cell Division; Gastrin-Releasing Peptide; Growth Substances; Lipoxygenase Inhibitors; Lung Neoplasms; Masoprocol; Membrane Proteins; Mice; Mice, Nude; Molecular Sequence Data; Peptides; RNA, Messenger; Signal Transduction; Somatomedins | 1996 |